These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 29667356)
1. Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference? Möckel M; von Haehling S; Vollert JO; Wiemer JC; Anker SD; Maisel A; ESC Heart Fail; 2018 Jun; 5(3):309-315. PubMed ID: 29667356 [TBL] [Abstract][Full Text] [Related]
2. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
3. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387 [TBL] [Abstract][Full Text] [Related]
4. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure. Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A; Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562 [TBL] [Abstract][Full Text] [Related]
6. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708 [TBL] [Abstract][Full Text] [Related]
7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
8. Setting the optimal threshold of NT-proBNP and BNP for the diagnosis of heart failure in patients over 75 years. Berthelot E; Bailly MT; Lehova XC; Rahmani MEB; Bounab R; Mewton N; Dobbs JE; Mas R; Frank M; Lellouche N; Paclot M; Jourdain P ESC Heart Fail; 2024 Oct; 11(5):3232-3241. PubMed ID: 38923835 [TBL] [Abstract][Full Text] [Related]
10. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP. Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917 [TBL] [Abstract][Full Text] [Related]
11. [The relevance of biomarkers in acute heart failure]. Hellenkamp K; von Haehling S Internist (Berl); 2019 Jun; 60(6):587-596. PubMed ID: 31089771 [TBL] [Abstract][Full Text] [Related]
12. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. Aimo A; Januzzi JL; Mueller C; Mirò O; Pascual Figal DA; Jacob J; Herrero-Puente P; Llorens P; Wussler D; Kozhuharov N; Sabti Z; Breidthardt T; Vergaro G; Ripoli A; Prontera C; Saccaro L; Passino C; Emdin M Int J Cardiol; 2019 Oct; 293():137-142. PubMed ID: 31200964 [TBL] [Abstract][Full Text] [Related]
13. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study. Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687 [TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Gaggin HK; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Walters EL; Januzzi JL; Am Heart J; 2017 Oct; 192():26-37. PubMed ID: 28938961 [TBL] [Abstract][Full Text] [Related]
15. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?). Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350 [TBL] [Abstract][Full Text] [Related]
16. Improving the diagnosis of acute heart failure using a validated prediction model. Steinhart B; Thorpe KE; Bayoumi AM; Moe G; Januzzi JL; Mazer CD J Am Coll Cardiol; 2009 Oct; 54(16):1515-21. PubMed ID: 19815122 [TBL] [Abstract][Full Text] [Related]
17. Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. Hoffmann U; Espeter F; Weiß C; Ahmad-Nejad P; Lang S; Brueckmann M; Akin I; Neumaier M; Borggrefe M; Behnes M BMC Cardiovasc Disord; 2015 Jun; 15():50. PubMed ID: 26072112 [TBL] [Abstract][Full Text] [Related]
18. Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea. Murray H; Cload B; Collier CP; Sivilotti ML CJEM; 2006 Jul; 8(4):251-8. PubMed ID: 17324304 [TBL] [Abstract][Full Text] [Related]
19. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]